NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-021-2021-0-PCT-02 NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF PCT PCT PCT/US2021/059941 Expired
NIAID E-238-2020-0-US-01 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) US 63/280,884 Abandoned
NCATS E-010-2022-0-PCT-02 Protein And Lipid Therapeutic Targets PCT PCT PCT/US2021/059641 Expired
NCATS E-010-2022-0-US-02 Protein And Lipid Therapeutic Targets US National Stage 18/037,406 Pending
NCI E-109-2016-0-US-14 TARGETED CANCER THERAPY US DIV 17/528,827 Pending
NCI E-059-2013-0-HK-23 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor HK EP 42021042576.5 Pending
NLM E-107-2010-2-US-35 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/528,492 Abandoned
NIAID E-023-2022-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 63/279,675 Abandoned
NICHD E-209-2021-0-US-03 Kits And Methods To Distinguish False Labor And True Labor US DIV 17/525,717 11906528 Issued PDF
NIAID E-171-2021-0-US-01 SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN US 63/278,956 Abandoned
NICHD E-010-2021-0-PCT-02 ENHANCED ANTIGEN REACTIVITY OF IMMUNE CELLS EXPRESSING A MUTANT NON-SIGNALING CD3 ZETA CHAIN PCT PCT PCT/US2021/059109 Expired
NIAID E-064-2016-1-US-08 PREFUSION RSV F PROTEINS AND THEIR USE US CON 17/524,380 11878998 Issued PDF
NCATS E-098-2019-0-US-03 A SCALABLE SYNTHESIS OF DUAL-TARGET INHIBITOR OF CANNABINOID-1 RECEPTOR AND INDUCIBLE NITRIC OXIDE SYNTHASE US National Stage 17/610,537 Pending
NCI E-044-2021-0-PCT-02 SMALL MOLECULE INHIBITORS OF STAT3 N-TERMINAL DOMAIN AND METHODS OF USE PCT PCT PCT/US2021/058936 Expired
NHLBI E-197-2020-0-PCT-02 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING PCT PCT PCT/US2021/058809 Expired
NICHD E-151-2021-0-US-01 Magnetic Resonance Method Of Measuring Water Exchange For Identifying Brain Physiology And Pathology US 63/277,881 Abandoned
NIA E-249-2016-0-US-19 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM US CON 17/522,687 11771657 Issued PDF
NHGRI E-034-2019-0-HK-16 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA HK EP 62021042143.9 Abandoned
NCI E-205-2021-0-US-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF US 63/277,287 Abandoned
NINR E-062-2022-0-PCT-03 Methods And Kits For Assessing Traumatic Brain Injury (TBI) Resulting From Blast Exposure PCT PCT PCT/US2021/072289 Expired
NIDDK E-011-2021-0-PCT-02 RNA SENSORS AND USES THEREOF PCT PCT PCT/IL2021/051318 Expired
NIDDK E-011-2021-0-US-02 RNA SENSORS AND USES THEREOF US National Stage 18/252,086 Pending
NINR E-062-2022-0-US-02 METHODS AND KITS FOR DETECTING TAU US ORD 17/453,991 Pending
NINR E-062-2022-0-EP-01 Methods And Kits For Assessing Traumatic Brain Injury (TBI) Resulting From Blast Exposure EP National Stage 21815867.3 Pending
NIAID E-251-2020-0-US-02 PPMO Targeting SARS-CoV-2 Genomic RNA To Treat And Prevent Coronavirus Infection US CIP 18/053,308 Pending
NCI E-231-2020-0-PC-01 RBD-ligand Utilization To Distinguish CAR-T Cells With Increased Anti-leukemia Effector Function PCT PCT PCT/EP2021/080796 Expired
NIAID E-060-2015-0-US-17 NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES US DIV 17/519,142 11938221 Issued PDF
NIAID E-064-2016-1-AU-09 SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS AND THEIR USE AU DIV 2021261932 Issued
NCI E-060-2021-0-PCT-02 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF PCT PCT PCT/US2021/058023 Expired
NCI E-064-2019-0-US-04 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 US National Stage 17/608,832 Pending
NCI E-060-2021-0-EP-01 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF EP National Stage 21820745.4 Pending
NIBIB E-168-2021-0-US-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy US 63/275,736 Abandoned
NIAID E-095-2021-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 63/275,936 Abandoned
NHLBI E-085-2019-0-CN-02 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE CN National Stage 202080033275.9 Issued
NHLBI E-005-2021-0-PCT-02 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE PCT PCT PCT/US2021/057845 Expired
NIAID E-081-2013-4-RU-20 Prefusion RSV F Proteins And Their Use RU DIV 2021132097 Pending
NIAID E-066-2020-1-NZ-13 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS USING THE CROSS-OVER-DUAL VARIABLE DOMAIN (CODV) FORMAT FOR TREATMENT OF HIV INFECTION NZ National Stage 782001 Pending
NIAID E-106-2016-0-US-05 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE US CON 17/517,597 11938177 Issued PDF
NIAID E-087-2019-0-US-03 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US National Stage 17/608,381 Pending
NHLBI E-322-2007-0-US-02 Nucleosides Protect Against Irradiation And Other Stresses US DIV 17/517,148 Pending
NCI E-150-2020-0-PCT-02 Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome PCT PCT PCT/US2021/057229 Expired
NCI E-015-2022-0-US-01 Cell Modification Device And Method For Automating Preparation of Personalized Tumor Vaccine US 63/273,819 Abandoned
NICHD E-200-2021-0-US-01 Use of Carboxypeptidase E / Neurotrophic Factor-Alpha 1 to Treat Neurodegenerative Disease US 63/273,312 Abandoned
NIAID E-128-2016-0-JP-01 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONOVIRUSES JP National Stage 2021-564446 Pending
NCI E-028-2015-1-CN-41 Anti-Mutated Kras T Cell Receptors CN DIV 202111263859.8 Issued
NCI E-021-2015-0-CN-34 Anti-CD70 Chimeric Antigen Receptors CN DIV 202111253336.5 Pending
NCI E-253-2020-0-PCT-02 SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF PCT PCT PCT/US2021/056548 Expired
NCI E-240-2015-1-CN-09 Methods of Analyzing Virus-Derived Therapeutics CN DIV 202111246733X Abandoned
NCI E-204-2021-0-US-01 Single Domain Antibodies Targeting The S2 Subunit Of SARS-CoV-2 Spike Protein US 63/271,854 Abandoned
NCI E-132-2012-0-US-12 ALTERING THE IMMUNDOMINANCE HIERARCHY USING A DNA VACCINE EXPRESSING CONSERVED REGIONS US CON 17/511,499 Abandoned